We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2588:HKEXBOC Aviation Limited Analysis

Data as of 2026-07-28 - not real-time

HK$78.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

BOC Aviation trades at HK$78, comfortably above its 20‑day (HK$78.08), 50‑day (HK$77.39) and 200‑day (HK$77.31) moving averages, signaling a bullish trend. The MACD has turned bullish and the RSI sits near the midpoint at 51, suggesting limited downside pressure while the price still respects a solid support zone around HK$74.2. The stock offers an attractive 4.5% dividend yield with a modest 36.7% payout, and its forward PE of 7.2 is well below the industry average of 31.3, indicating relative value. However, the DCF fair value of HK$28 is far beneath the market price, reflecting a potential overvaluation on a cash‑flow basis, compounded by a high debt‑to‑equity ratio of over 250% and negative free cash flow. The recent announcement of a sizeable order for up to 220 Pratt & Whitney engines, capable of powering 110 A320neo aircraft, underscores growth prospects for the fleet.
Overall, the stock sits in a bullish technical environment with strong dividend appeal, but investors must weigh the leverage and cash‑flow gap against the upside implied by analyst targets (median HK$93) and the extreme‑greed market sentiment.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above all major SMAs and bullish MACD crossover
  • Strong dividend yield with manageable payout ratio
  • Support level at HK$74.2 providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst median target price of HK$93 implies ~20% upside
  • Order for 220 Pratt & Whitney engines expands fleet capacity
  • Forward PE of 7.2 vs industry PE of 31.3 indicates valuation headroom

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage (debt‑to‑equity >250%) and negative free cash flow
  • Geographic concentration in China exposing regulatory and macro risk
  • Sustainable dividend and long‑term lease contracts underpin cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
Profit Margin34.28%
P/E Ratio8.8
ROE11.92%
ROA3.33%
Debt/Equity251.35
P/B Ratio1.0
Op. Cash FlowHK$2.9B
Free Cash FlowHK$-2275338240
Industry P/E31.3

Technical Analysis

TrendBullish
RSI51.1
SupportHK$74.20
ResistanceHK$82.65
MA 20HK$78.08
MA 50HK$77.39
MA 200HK$77.31
MACDBullish
VolumeDecreasing
Fear & Greed Index88.91

Valuation

Fair ValueHK$28.25
Target PriceHK$93.72
Upside/Downside20.15%
GradeUndervalued
TypeBlend
Dividend Yield4.52%

Risk Assessment

Beta0.40
Volatility25.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.